Basic Information
ID: ALA5261635
Type: Binding
Description: Inhibition of BRD9 in human PC-9 cells assessed as reduction in ALDH1A1 gene expression at 2 uM preincubated with erlotinib for 8 days followed by compound addition and measured after 24 hrs by RNA sequencing analysis
Format: BAO_0000219
Organism: Homo sapiens
Cell type: PC-9
Target: Bromodomain-containing protein 9(ALA3108640)
Document: ALA5260810
Inhibition of BRD9 in human PC-9 cells assessed as reduction in ALDH1A1 gene expression at 2 uM preincubated with erlotinib for 8 days followed by compound addition and measured after 24 hrs by RNA sequencing analysis: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA5261635
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 377.44 | 3.05 | 3.05 |